Avalo Therapeutics, Inc. (AVTX) Competitors

$4.76

$0.29 (6.49%)
Last update: 04:00 PM EST
Day's range
$4.47
Day's range
$4.9

Avalo Therapeutics, Inc. Competitors

Symbol Share Price Market Cap P/E Ratio Employee Count
IPSC

Century Therapeutics, Inc.

$0.59 $50.38 M -2.17 140
ACRV

Acrivon Therapeutics, Inc. Common Stock

$1.24 $39.19 M -0.58 75
EWTX

Edgewise Therapeutics, Inc.

$14.47 $1.52 B -9.33 117
CGEM

Cullinan Oncology, Inc.

$8.16 $480.97 M -2.94 111
MLYS

Mineralys Therapeutics, Inc.

$13.73 $895.51 M -3.66 51
CCCC

C4 Therapeutics, Inc.

$1.44 $101.90 M -0.97 110
ANAB

AnaptysBio, Inc.

$23.39 $685.74 M -4.9 136
ALXO

ALX Oncology Holdings Inc.

$0.49 $25.88 M -0.2 65
GPCR

Structure Therapeutics Inc.

$21.62 $1.25 B -8.39 163
AVTE

Aerovate Therapeutics, Inc.

$9.41 $77.68 M -0.05 4
PMVP

PMV Pharmaceuticals, Inc.

$1.10 $57.41 M -0.94 47
ACLX

Arcellx, Inc.

$63.82 $3.52 B -21.34 163
BNOX

Bionomics Limited

$6.66 $4.95 M -0.02 8
ALZN

Alzamend Neuro, Inc.

$3.02 $2.40 M 0 4
ZIVO

ZIVO Bioscience, Inc.

$14.22 $59.21 M -3.72 7
MIRO

Miromatrix Medical Inc.

$3.39 $92.95 M -2.97 76
ANEB

Anebulo Pharmaceuticals, Inc.

$1.55 $54.27 M -5.28 2
VRAX

Virax Biolabs Group Limited

$0.81 $3.52 M -0.31 17
KRBP

Kiromic BioPharma, Inc.

$0.03 $477.95 K -0.06 44
BNTC

Benitec Biopharma Inc.

$14.94 $388.24 M -2.94 16
MOLN

Molecular Partners AG

$3.81 $137.83 M -1.8 158